UTHR
UNITED THERAPEUTICS Corp
Key Financials
Revenue
$3.2B
↑ 10.6%
Net Income
$1.3B
↑ 11.7%
Operating Income
$1.5B
↑ 8.4%
Gross Profit
$2.8B
↑ 9.0%
EPS (Diluted)
$27.86
↑ 13.1%
Total Assets
$7.9B
↑ 7.0%
Shareholders' Equity
$7.1B
↑ 10.1%
Cash & Equivalents
$1.6B
↓ 8.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/9/2026 | View on SEC |
| 4 | 10/8/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/6/2026 | View on SEC |
| 4 | 10/5/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/1/2026 | View on SEC |
| 4 | 10/1/2026 | View on SEC |
| 4 | 10/1/2026 | View on SEC |
| 144 | 10/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | UTHR |
| Company Name | UNITED THERAPEUTICS Corp |
| CIK | 1082554 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 3016089292 |